Recently, one research group identified that diosgenin promoted apoptosis and triggered cell cycle arrest at the G2/M phase through regulation of Chk1 kinase, Cdc25c pathway, and Bcl-2 in breast cancer cells [17]. This evidence concerns the gene CDC25C and breast carcinoma.